Cardiac Insight has raised $2 million to ramp up sales of its CardeaScreen handheld device and complete Food and Drug Administration approval for upcoming products.
Cardiologists and college and professional sports teams use Cardiac Insight's CardeaScreen handheld device to detect heart problems in young athletes and identifying those at risk of sudden cardiac arrest.
“As we see more commercial opportunity for sales we raise more,” said co-founder and CEO Brad Harlow. “It was an opportunity…
Cardiac Insight has raised $2 million to ramp up sales of its CardeaScreen handheld device and complete Food and Drug Administration approval for upcoming products.
Cardiologists and college and professional sports teams use Cardiac Insight's CardeaScreen handheld device to detect heart problems in young athletes and identifying those at risk of sudden cardiac arrest.
“As we see more commercial opportunity for sales we raise more,” said co-founder and CEO Brad Harlow. “It was an opportunity…